Real-time enrollment status for this cyp2c19 genetic variants clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:46 AM UTC
| NCT Number | NCT05078723 |
| Recruiting Status | Recruiting |
| Condition | CYP2C19 Genetic Variants |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Stanford University |
| Last Updated on CT.gov | December 16, 2024 (Dec 16, 2024) |
As of July 13, 2026: Clinical trial NCT05078723 is currently recruiting participants. This clinical trial study for cyp2c19 genetic variants is actively seeking new participants at 1 location across the United States. The study is sponsored by Stanford University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05078723 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05078723 was last updated Dec 16, 2024 (December 16, 2024). HelloStudys verifies this status automatically.